Section 441A.600 - Lymphogranuloma venereum1. The health authority shall investigate each report of a case having lymphogranuloma venereum to confirm the diagnosis, to determine the source or possible source of the infection and to ensure the case and any contacts have received appropriate testing and medical treatment for the disease.2. Except as otherwise provided in NRS 441A.210, a person with lymphogranuloma venereum shall obtain medical treatment for the disease.3. The health care provider for a person with lymphogranuloma venereum shall notify the health authority immediately if the person fails to submit to medical treatment or fails to complete the prescribed course of medical treatment. Except as otherwise provided in NRS 441A.210, the health authority shall take action to ensure that the person receives appropriate medical treatment for the disease.4. A clinic, dispensary or health care provider that accepts supplies or aid from the Division shall provide counseling and take such measures for the testing, treatment, prevention, suppression and control of lymphogranuloma venereum as are specified in "Sexually Transmitted Infections Treatment Guidelines, 2021," adopted by reference pursuant to NAC 441A.200.5. A health care provider shall follow the procedures set forth in "Sexually Transmitted Infections Treatment Guidelines, 2021," adopted by reference pursuant to NAC 441A.200, when testing and treating persons with lymphogranuloma venereum.Nev. Admin. Code § 441A.600
Added to NAC by Bd. of Health, eff. 1-24-92; A by R087-08, 1-13-2011; A by R148-22A, eff. 7/26/2023; A by R002-22A, eff. 9/18/2023